Supporting Gene Therapy Development with Safer, More Efficacious AAV Vectors
By SIRION BiotechSIRION Biotech supports clients developing viral vectors for safer and more efficacious drug products. At SIRION, we combine our technology, experience, and capabilities, with external partners to provide an accelerated gene therapy vector development program.
To read more, please download this free white paper.